digestive/alimentary system
• increase in apoptosis of gut epithelial cells
|
• intestinal wall is diffusely thickened
|
• epithelial cell damage in the intestine is associated with intraepithelial neutrophils, lymphocytes, and occasional crypt abscesses
|
• mice exhibit a patchy interstitial infiltrate without interstitial fibrosis indicating focal interstitial inflammation
• intestine shows an increase in the number of IgA+ plasma cells that massively infiltrate the lamina propria, with many lymphoid follicle-like structures infiltrating the lamina propria of the colon
• mice develop intestinal inflammation with increased lamina propria neutrophils, lymphocytes, plasma cells, and focal epithelial damage
• many of the lamina propria leukocytes are T cells and granulocytes
|
• at 5-8 months of age, mice develop a colitis like disease with a diffuse thickening of the intestinal wall, inflammatory cell infiltrate in the lamina propria and submucosa, and prominent germinal center formation in a diffuse pattern
|
• the small intestine is inflamed in 6 month old mice
|
cellular
• increase in apoptosis of gut epithelial cells
|
• T cells isolated from mice are in a hyper-proliferative state with blastogenic qualities
• there is more than a three fold expansion in the percentage of T cells expressing CD62LlowCD44high activation markers
|
hematopoietic system
• splenomegaly is evident at 5-8 months of age
• mean weight of spleen is 339.6 mg compared to 88.5 mg in wild-type mice
|
• the number of splenocytes is about double that of control
|
• hematopoiesis of the granulocyte / macrophage lineage is detected in the spleen
|
• serum IgA levels are elevated up to 30- to 40-fold by 6-8 months of age
• serm IgA levels are 10-fold higher as early as 7 weeks of age, before intestinal inflammation is identifiable
• mice exhibit increased glomeruli mesangial deposition of IgA
• serum predominantly contains polymeric IgA rather than monomeric IgA
|
• mice show IgG deposition in the glomeruli
|
• T cells disrupt lipid homeostasis in these mice as evidenced by the hypertriglyceridemia and hypercholesterolemia
(J:120962)
• transgenic T cells transferred into wild-type hosts cause rises in serum cholesterol
(J:120962)
• transgenic T cells also cause a rise in cholesterol levels when transferred into LDLRtm1Her null mice
(J:120962)
• there is a three-fold increase in GM-CSF production by splenocytes
(J:129951)
• there is a five-fold increase in the number of T cells secreting IFN-gamma after in vitro activation
(J:129951)
• there is also an increase in the number of T cells producing IL-4
(J:129951)
|
• T cells isolated from mice are in a hyper-proliferative state with blastogenic qualities
• there is more than a three fold expansion in the percentage of T cells expressing CD62LlowCD44high activation markers
|
immune system
• splenomegaly is evident at 5-8 months of age
• mean weight of spleen is 339.6 mg compared to 88.5 mg in wild-type mice
|
• the number of splenocytes is about double that of control
|
• serum IgA levels are elevated up to 30- to 40-fold by 6-8 months of age
• serm IgA levels are 10-fold higher as early as 7 weeks of age, before intestinal inflammation is identifiable
• mice exhibit increased glomeruli mesangial deposition of IgA
• serum predominantly contains polymeric IgA rather than monomeric IgA
|
• mice show IgG deposition in the glomeruli
|
• T cells disrupt lipid homeostasis in these mice as evidenced by the hypertriglyceridemia and hypercholesterolemia
(J:120962)
• transgenic T cells transferred into wild-type hosts cause rises in serum cholesterol
(J:120962)
• transgenic T cells also cause a rise in cholesterol levels when transferred into LDLRtm1Her null mice
(J:120962)
• there is a five-fold increase in the number of T cells secreting IFN-gamma after in vitro activation
(J:129951)
• there is also an increase in the number of T cells producing IL-4
(J:129951)
• there is a three-fold increase in GM-CSF production by splenocytes
(J:129951)
|
• T cells isolated from mice are in a hyper-proliferative state with blastogenic qualities
• there is more than a three fold expansion in the percentage of T cells expressing CD62LlowCD44high activation markers
|
• mice exhibit increased glomerular deposition of complement C3
|
• ratio of T cells to B cells is almost 5-fold greater than in controls
|
• lymph nodes are larger by 5-8 months of age
• there is a 7-fold increase in the number of lymph node cells
• the increase in cell number is due expansion of the T cell zone
|
• rheumatoid factors are increased in these mice
|
• presence of anti-DNA IgA antibody in aged mice
|
• anti-DNA antibody levels are eight-fold higher than controls
|
• IgA level in fecal extracts of aged mice is decreased indicating reduced IgA secretion
• transgenic mice administered a labeled polymeric IgA intravenously show a higher level of polymeric IgA in serum compared to wild-type mice indicating a longer half-life and that mice have defects in clearing the polymeric IgA from the circulation
|
• mice exhibit a patchy interstitial infiltrate without interstitial fibrosis indicating focal interstitial inflammation
• intestine shows an increase in the number of IgA+ plasma cells that massively infiltrate the lamina propria, with many lymphoid follicle-like structures infiltrating the lamina propria of the colon
• mice develop intestinal inflammation with increased lamina propria neutrophils, lymphocytes, plasma cells, and focal epithelial damage
• many of the lamina propria leukocytes are T cells and granulocytes
|
• at 5-8 months of age, mice develop a colitis like disease with a diffuse thickening of the intestinal wall, inflammatory cell infiltrate in the lamina propria and submucosa, and prominent germinal center formation in a diffuse pattern
|
• the small intestine is inflamed in 6 month old mice
|
• inflammatory infiltrate in the portal areas of the liver are observed
|
• mice spontaneously develop diffuse global proliferative glomerulonephritis
involving over 80% of the glomeruli
• the involved glomeruli are diffusely enlarged, demonstrating mesangial prominence and intracapillary and extracapillary proliferation with obliteration of the capillary lumina
• basement membranes are thickened
|
• inflammatory infiltrate in the pulmonary interstitial is observed
|
liver/biliary system
• inflammatory infiltrate in the portal areas of the liver are observed
|
• at 4 to 8 weeks of age, T cell numbers are increased in the liver without any signs of inflammation
|
muscle
respiratory system
• inflammatory infiltrate in the pulmonary interstitial is observed
|
homeostasis/metabolism
• cholesterol levels are almost double those of control as 4 to 8 weeks of age
• cholesterol levels are more than double those controls when mice are fed a high-fat diet
|
• circulating triglyceride levels are elevated by 4 to 8 weeks of age
• this hypertriglyceridemia is elevated further when mice are fed a high-fat diet
|
• mice exhibit increased glomerular deposition of complement C3
|
• aged mice exhibit proteinuria
|
integument
• plaque-like cutaneous lesions ranging from 0.3 cm to 2 cm along with ulceration and scar formation occur in virtually all mice by 5 months of age
|
renal/urinary system
• aged mice exhibit proteinuria
|
• mice exhibit increased glomerular deposition of IgA and complement C3
• mice show IgG and weak IgM deposition in the glomeruli
|
• mice spontaneously develop diffuse global proliferative glomerulonephritis
involving over 80% of the glomeruli
• the involved glomeruli are diffusely enlarged, demonstrating mesangial prominence and intracapillary and extracapillary proliferation with obliteration of the capillary lumina
• basement membranes are thickened
|
• kidney shows a wide acellular mesangium filled with a periodic acid-Schiff+ material
|
• glomeruli are almost entirely sclerotic in some mice
|
• Ig deposits are visible in a coarsely-granular manner
|
growth/size/body
• splenomegaly is evident at 5-8 months of age
• mean weight of spleen is 339.6 mg compared to 88.5 mg in wild-type mice
|
• the number of splenocytes is about double that of control
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
IgA glomerulonephritis | DOID:2986 |
OMIM:161950 |
J:128976 |